Cargando…

Diabetes risk associated with plasma epoxylipid levels

Detalles Bibliográficos
Autor principal:	Imig, John D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050865/ https://www.ncbi.nlm.nih.gov/pubmed/33857907 http://dx.doi.org/10.1016/j.ebiom.2021.103331

Ejemplares similares

Mitochondrial Dysfunction and Inflammaging in Heart Failure: Novel Roles of CYP-Derived Epoxylipids
por: Keshavarz-Bahaghighat, Hedieh, et al.
Publicado: (2020)

Plasma Ceramides Target Skeletal Muscle in Type 2 Diabetes
por: Kirwan, John P.
Publicado: (2013)

Rushing to maintain plasma membrane phosphoinositide levels
por: Balla, Tamas
Publicado: (2020)

Microalbuminuria and diabetic retinopathy in type 2 diabetic patients: From risk association to risk prediction
por: Chang, Chia‐Hsuin, et al.
Publicado: (2013)

Imminent risk of COVID-19 in diabetes mellitus and undiagnosed diabetes mellitus patients
por: John, Jyoti Elgiva, et al.
Publicado: (2020)

Plasma Biomarkers of HIV-associated Cognitive Disease
por: Winston, Alan, et al.
Publicado: (2015)

Antidepressant drug use and future diabetes risk
por: Kivimäki, M., et al.
Publicado: (2011)

Plasma Aβ: A Possible Missing Link Between Alzheimer Disease and Diabetes
por: Sato, Naoyuki, et al.
Publicado: (2013)

Plasma as a resuscitation fluid for volume‐depleted shock: Potential benefits and risks
por: van den Brink, Daan P., et al.
Publicado: (2021)

Comment on: Serum cholesterol and LDL-C in association with level of diastolic blood pressure in type 2 diabetic patients
por: Nasri, Hamid
Publicado: (2012)

The predictive utility of circulating PCSK9 levels on diabetes mellitus
por: Peng, Jia, et al.
Publicado: (2021)

Sarcopenia and diabetes: Hyperglycemia is a risk factor for age-associated muscle mass and functional reduction
por: Umegaki, Hiroyuki
Publicado: (2015)

Renal cell carcinoma and plasma cell myeloma: Coincidence or true association?
por: Mubarak, Muhammed
Publicado: (2014)

Diabetic Kidney Disease: A Determinant of Cardiovascular Risk in Type 1 Diabetes
por: de Boer, Ian H., et al.
Publicado: (2018)

The residual cardiorenal risk in type 2 diabetes
por: Giugliano, Dario, et al.
Publicado: (2021)

Targeting Plasma Cells in Autoimmune Diseases
por: Tarlinton, David M., et al.
Publicado: (2004)

Epigenetics and Diabetes Risk: Not Just for Imprinting Anymore?
por: Pollin, Toni I.
Publicado: (2011)

Diabetic Nephropathy: Emerging Biomarkers for Risk Assessment
por: Badal, Shawn S., et al.
Publicado: (2015)

Genes Associated With Risk of Type 2 Diabetes Identified by a Candidate-Wide Association Scan: As a Trickle Becomes a Flood
por: Rich, Stephen S., et al.
Publicado: (2008)

Oral hygiene improvement: a pragmatic approach based upon risk and motivation levels
por: Sgan-Cohen, Harold D
Publicado: (2008)

Famine From Feast: Low Red Cell Vitamin C Levels in Diabetes()
por: May, James M.
Publicado: (2015)

The Benefits and Risks of New Therapies for Type 2 Diabetes
por: Asche, Car V., et al.
Publicado: (2008)

Searching for Monogenic Diabetes in a High-risk Autoimmune Diabetes Cohort: Needles in a Paperclip Stack
por: Gamu, Daniel, et al.
Publicado: (2021)

Improving Prediction of Risk for the Development of Type 1 Diabetes—Insights From Populations at High Risk
por: Wherrett, Diane K.
Publicado: (2021)

Advances in Risk Prediction of Type 2 Diabetes: Integrating Genetic Scores With Framingham Risk Models
por: Keating, Brendan J.
Publicado: (2015)

A holistic approach to predicting diabetes risk via biomarkers
por: Cohen, Alan A.
Publicado: (2021)

Commentary for distribution and risk factors of postoperative endophthalmitis in people with diabetes
por: Mahendradas, Padmamalini, et al.
Publicado: (2021)

Lipodistrophy and Associated Risk Factors in Insulin-Treated People With Diabetes
por: Gentile, Sandro, et al.
Publicado: (2016)

Diagnosing Gestational Diabetes Mellitus: Rationed or Rationally Related to Risk?
por: McIntyre, Harold David
Publicado: (2013)

Intensive risk factor management and cardiovascular autonomic neuropathy in type 2 diabetes in the Action to Control Cardiovascular Risk in Diabetes trial: A post‐hoc analysis
por: Aso, Yoshimasa
Publicado: (2021)

Is Brain Insulin Action Relevant to the Control of Plasma Glucose in Humans?
por: Edgerton, Dale S., et al.
Publicado: (2015)

Are people with uncontrolled diabetes mellitus at high risk of reinfections with COVID-19?
por: Pal, Rimesh, et al.
Publicado: (2021)

Targeting Hepatic Glucokinase in Type 2 Diabetes: Weighing the Benefits and Risks
por: Agius, Loranne
Publicado: (2009)

Mortality Risk in Long-Standing Type 1 Diabetes: Hope and Concern
por: Hamman, Richard F.
Publicado: (2010)

Is Estradiol a Biomarker of Type 2 Diabetes Risk in Postmenopausal Women?
por: Mauvais-Jarvis, Franck
Publicado: (2017)

Aging and Diabetes: Shifting the Risk Trajectory With High-Sensitivity Cardiac Troponins
por: Neeland, Ian J., et al.
Publicado: (2020)

Commentary on risk factors for first and subsequent cardiovascular disease events in type 1 diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study
por: Lin, Chun‐Hsien, et al.
Publicado: (2020)

Serosurveys and convalescent plasma in COVID-19
por: Pérez-Cameo, Cristina, et al.
Publicado: (2020)

Association of Obesity, Diabetes, and Risk of Tuberculosis: Two Population-Based Cohorts
por: Lin, Hsien-Ho, et al.
Publicado: (2018)

Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3hbd6mo2m2iokbuejhmn7ft132